+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cyclodextrin in Pharma Market - Global Forecast 2025-2030- Product Image
Cyclodextrin in Pharma Market - Global Forecast 2025-2030- Product Image
Sale

Cyclodextrin in Pharma Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6126886
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global cyclodextrin in pharmaceuticals market is undergoing significant transformation, driven by rapid technological advancements and evolving regulatory landscapes. This report equips senior decision-makers with an actionable analysis of market dynamics, supply chain strategies, innovative applications, and competitive intelligence—positioning organizations to make informed investments and maintain a competitive advantage.

Market Snapshot: Cyclodextrin in Pharmaceuticals

Cyclodextrins have become essential excipients across drug development, supporting enhanced solubility and stability for increasingly complex pharmaceutical compounds. The market is shaped by accelerated adoption of sustainable manufacturing practices, optimization of supply chains in the face of shifting global tariffs, and regulatory clarity for novel cyclodextrin derivatives. Growing application diversity—from oral to parenteral routes—underscores the expanding role of cyclodextrin in next-generation therapies. Senior stakeholders now recognize cyclodextrin’s importance for addressing therapeutic delivery challenges, regional sourcing priorities, and advancing formulation innovation.

Scope & Segmentation

This comprehensive report examines the cyclodextrin in pharmaceuticals market through rigorous segmentation and strategic analysis:

  • Product Types: Hydroxypropyl Beta, Methyl Beta, Sulfobutyl Ether Beta, Alpha, Beta, and Gamma cyclodextrins.
  • Routes of Administration: Nasal drops and sprays, ophthalmic drops, oral liquids (suspensions, syrups) and solids (capsules, powders, tablets), parenteral (intramuscular, intravenous), and topical formations including creams, gels, and ointments.
  • Applications: Drug delivery systems focusing on controlled and targeted release, solubility enhancement, stability improvement, and taste masking.
  • Therapeutic Areas: Cardiovascular (antihypertensive, lipid lowering), central nervous system (antidepressants, neuroprotective agents), infectious diseases (antibiotics, antivirals), and oncology (chemotherapeutic and immunotherapy agents).
  • Regions: Americas (U.S., Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and emerging markets), and Asia-Pacific (China, India, Japan, Australia, South Korea, and key Southeast Asian countries).
  • Companies Covered: Roquette Frères, Wacker Chemie AG, Tokyo Chemical Industry Co., Ltd., Daicel Corporation, Ashland Global Holdings Inc., CycloLab Ltd., CycloChem Technologies Pvt. Ltd., Samyang Corporation, Cerbios-Pharma SA, and Caldic B.V.

Cyclodextrin in Pharmaceuticals: Key Takeaways

  • Rising demand for advanced excipients is fueled by the need to address poor drug solubility, enable controlled release, and support new routes of administration.
  • Regulatory frameworks across major markets, including the U.S. and EU, have clarified approval requirements for modified cyclodextrin derivatives, reducing barriers to global market entry.
  • Innovations in continuous manufacturing and adoption of green chemistry are helping manufacturers reduce costs, minimize environmental impact, and improve scalability.
  • Collaborative models—linking excipient suppliers, contract development partners, and academic institutions—are accelerating time-to-market for new inclusion complexes.
  • Regional supply chain diversification and nearshoring strategies are helping companies mitigate risks posed by raw material tariffs and logistical disruptions.
  • Increasing investment in digital health platforms and computational modeling is transforming early-stage formulation, making the prediction and optimization of drug-cyclodextrin interactions more efficient.

Tariff Impact & Supply Chain Optimization

With newly enacted and proposed U.S. tariffs on key intermediates, pharmaceutical manufacturers face pressure on cyclodextrin procurement costs. Leading companies are mitigating these effects by partnering with regional suppliers, pursuing nearshoring in North America and Europe, and evaluating alternative synthetic pathways. Improved inventory management and strategic vendor relationships are designed to safeguard operational continuity and control working capital exposure.

Methodology & Data Sources

This report is built on a robust methodology integrating thorough secondary research with primary interviews. Scientific literature, patent filings, and regulatory guidance were analyzed, complemented by expert interviews in formulation science, supply chains, and regulatory affairs. Rigorous triangulation and independent peer review support the reliability of these insights.

Why This Report Matters

  • Enables strategic planning by mapping emerging regional growth centers and technology adoption trends for cyclodextrin in pharmaceuticals.
  • Supports competitive positioning through in-depth coverage of regulatory, supply chain, and partnership strategies shaping global market dynamics.
  • Empowers operational and R&D decision-making with up-to-date intelligence on leading manufacturer initiatives and innovation trends.

Conclusion

The cyclodextrin in pharmaceuticals market stands at the intersection of regulatory evolution, technological progress, and dynamic global supply strategies. Leaders equipped with up-to-date insights will be positioned to navigate complexity and capture innovation-driven opportunities.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advances in nanoparticle-based drug delivery using hydroxypropyl-ß-cyclodextrin inclusion complexes to enhance oral bioavailability
5.2. Regulatory framework evolution driving increased integration of cyclodextrin excipients in injectable pharmaceutical formulations
5.3. Innovative use of methylated cyclodextrin derivatives in targeted oncology therapies to minimize off-target toxicity
5.4. Emerging applications of cyclodextrin-based adjuvants in nasal and pulmonary vaccine delivery for enhanced immune response
5.5. Breakthrough stabilization techniques for oral peptide and protein drugs employing cyclodextrin conjugation to improve absorption
5.6. Growth of cyclodextrin-based ocular drug delivery systems aimed at prolonging retention time and improving patient compliance
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cyclodextrin in Pharma Market, by Product Type
8.1. Introduction
8.2. Modified
8.2.1. Hydroxypropyl Beta
8.2.2. Methyl Beta
8.2.3. Sulfobutyl Ether Beta
8.3. Natural
8.3.1. Alpha
8.3.2. Beta
8.3.3. Gamma
9. Cyclodextrin in Pharma Market, by Route of Administration
9.1. Introduction
9.2. Nasal
9.2.1. Drops
9.2.2. Sprays
9.3. Ophthalmic
9.3.1. Drops
9.4. Oral
9.4.1. Liquid
9.4.1.1. Suspensions
9.4.1.2. Syrups
9.4.2. Solid
9.4.2.1. Capsules
9.4.2.2. Powders
9.4.2.3. Tablets
9.5. Parenteral
9.5.1. Intramuscular
9.5.2. Intravenous
9.6. Topical
9.6.1. Creams
9.6.2. Gels
9.6.3. Ointments
10. Cyclodextrin in Pharma Market, by Application
10.1. Introduction
10.2. Drug Delivery System
10.2.1. Controlled Release
10.2.1.1. Extended Release
10.2.1.2. Sustained Release
10.2.2. Targeted Delivery
10.3. Solubility Enhancement
10.4. Stability Improvement
10.5. Taste Masking
11. Cyclodextrin in Pharma Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.2.1. Antihypertensive Agents
11.2.2. Lipid Lowering Agents
11.3. Central Nervous System
11.3.1. Antidepressants
11.3.2. Neuroprotective Agents
11.4. Infectious Diseases
11.4.1. Antibiotic Agents
11.4.2. Antiviral Agents
11.5. Oncology
11.5.1. Chemotherapeutic Agents
11.5.2. Immunotherapy Agents
12. Americas Cyclodextrin in Pharma Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Cyclodextrin in Pharma Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Cyclodextrin in Pharma Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roquette Frères
15.3.2. Wacker Chemie AG
15.3.3. Tokyo Chemical Industry Co., Ltd.
15.3.4. Daicel Corporation
15.3.5. Ashland Global Holdings Inc.
15.3.6. CycloLab Ltd.
15.3.7. CycloChem Technologies Pvt. Ltd.
15.3.8. Samyang Corporation
15.3.9. Cerbios-Pharma SA
15.3.10. Caldic B.V.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CYCLODEXTRIN IN PHARMA MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. CYCLODEXTRIN IN PHARMA MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. CYCLODEXTRIN IN PHARMA MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. CYCLODEXTRIN IN PHARMA MARKET: RESEARCHAI
FIGURE 24. CYCLODEXTRIN IN PHARMA MARKET: RESEARCHSTATISTICS
FIGURE 25. CYCLODEXTRIN IN PHARMA MARKET: RESEARCHCONTACTS
FIGURE 26. CYCLODEXTRIN IN PHARMA MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CYCLODEXTRIN IN PHARMA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY HYDROXYPROPYL BETA, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY HYDROXYPROPYL BETA, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY METHYL BETA, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY METHYL BETA, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SULFOBUTYL ETHER BETA, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SULFOBUTYL ETHER BETA, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ALPHA, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ALPHA, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY BETA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY BETA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GAMMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GAMMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SPRAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DROPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DROPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SYRUPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SYRUPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY POWDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY POWDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLUBILITY ENHANCEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLUBILITY ENHANCEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY STABILITY IMPROVEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY STABILITY IMPROVEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TASTE MASKING, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TASTE MASKING, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIHYPERTENSIVE AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIHYPERTENSIVE AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIPID LOWERING AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIPID LOWERING AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NEUROPROTECTIVE AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NEUROPROTECTIVE AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIBIOTIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIBIOTIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ANTIVIRAL AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CHEMOTHERAPEUTIC AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CHEMOTHERAPEUTIC AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY IMMUNOTHERAPY AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY IMMUNOTHERAPY AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS CYCLODEXTRIN IN PHARMA MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES CYCLODEXTRIN IN PHARMA MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 223. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 224. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 225. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2024 (USD MILLION)
TABLE 226. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2025-2030 (USD MILLION)
TABLE 227. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 228. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 229. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2024 (USD MILLION)
TABLE 232. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2025-2030 (USD MILLION)
TABLE 233. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 234. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 235. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 236. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 237. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 238. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 239. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 240. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 241. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 242. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 243. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 244. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 245. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 246. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 247. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 248. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 249. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 250. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 251. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 252. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 253. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 254. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 255. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 256. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 257. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 258. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 259. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 260. CANADA CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 261. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 262. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 263. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2024 (USD MILLION)
TABLE 264. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2025-2030 (USD MILLION)
TABLE 265. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 266. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 267. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 268. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 269. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2024 (USD MILLION)
TABLE 270. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2025-2030 (USD MILLION)
TABLE 271. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 272. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 273. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 274. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 275. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 276. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 277. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 278. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 279. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 280. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 281. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 282. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 283. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 286. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 287. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 288. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 289. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 290. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 291. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 292. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 293. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 294. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 295. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 296. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 297. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 298. MEXICO CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY MODIFIED, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NATURAL, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY NASAL, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY OPHTHALMIC, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY LIQUID, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY SOLID, 2025-2030 (USD MILLION)
TABLE 317. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 318. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 319. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 320. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 321. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 322. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 323. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2018-2024 (USD MILLION)
TABLE 324. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY DRUG DELIVERY SYSTEM, 2025-2030 (USD MILLION)
TABLE 325. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2018-2024 (USD MILLION)
TABLE 326. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CONTROLLED RELEASE, 2025-2030 (USD MILLION)
TABLE 327. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 328. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 329. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 330. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 331. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 332. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 333. BRAZIL CYCLODEXTRIN IN PHARMA MARKET SIZE, BY INFECTIOUS DISEASES, 2018-

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Cyclodextrin in Pharma market report include:
  • Roquette Frères
  • Wacker Chemie AG
  • Tokyo Chemical Industry Co., Ltd.
  • Daicel Corporation
  • Ashland Global Holdings Inc.
  • CycloLab Ltd.
  • CycloChem Technologies Pvt. Ltd.
  • Samyang Corporation
  • Cerbios-Pharma SA
  • Caldic B.V.

Related Topics

Related Reports

Cyclodextrin - Global Strategic Business Report - Product Image

Cyclodextrin - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Beta-Cyclodextrin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Beta-Cyclodextrin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 88 Pages
  • Global
From
(2-Hydroxypropyl)-Beta-Cyclodextrin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

(2-Hydroxypropyl)-Beta-Cyclodextrin Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 79 Pages
  • Global
From
Dextrin - Global Strategic Business Report - Product Image

Dextrin - Global Strategic Business Report

  • Report
  • 288 Pages
  • Global
From
Cyclodextrin (CAS 12619-70-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Cyclodextrin (CAS 12619-70-4) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.